1. Home
  2. Clinical Topics
  3. Cardio-Pulmonary
  4. Gender bias in FDA premarket approval of cardiovascular devices
Cardio-PulmonaryClinical TopicsDrugs and DevicesNewsPatient SafetyWeb ExclusivesWomen's HealthWorkplace Management

Gender bias in FDA premarket approval of cardiovascular devices

Share

A systematic review of high-risk cardiovascular devices receiving premarket approval from the U.S. Food and Drug Administration (FDA) found that women were under-represented in the evidence presented to the FDA.  Read more at http://circoutcomes.ahajournals.org/content/early/2011/03/01/CIRCOUTCOMES.110.958215.abstract.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts